Two-Year Real-World Treat and Extend Patterns and Fluid Outcomes Among Neovascular Age-Related Macular Degeneration Patients Treated With Anti-VEGFs

Related

• 

  Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry

  Jeremiah Brown, MD, MS, FASRS

  Annual Meeting Talks

  2020

• 

  Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)

  Dante Joseph Pieramici, MD

  Annual Meeting Talks

  2020

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024